Dr. Robyn Alison Lamar, MD

Dr. Lamar practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Lamar's NPI, 1295062321, was assigned on November 10, 2009. Dr. Lamar graduated from UCSF School of Medicine in 2007. Dr. Lamar holds California license A 106423.

Dr. Lamar's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Lamar's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Lamar is also affiliated with San Francisco Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Lamar to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lamar practices, 2 sites in all. Vendor and product names are available with a free account.

Obstetrics and gynecology is Dr. Lamar's primary specialty in the NPI Registry, under taxonomy code 207V00000X. Dr. Lamar is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dr. Lamar is licensed in California.

Dmand AI lists menopause, pelvic prolapse and vaginal infection among the conditions Dr. Lamar treats.

CMS data shows 137 Medicare services from Dr. Lamar across 3 procedure codes in 2024, all of them office visits, for 94 Medicare patients. Medicare paid $11,014 for them. Every service was in an office.

CMS counts 94 Medicare patients who saw Dr. Lamar in 2024. The largest group is 65 to 74, with 49 patients. 66% of them have high cholesterol, and 44% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lamar's median patient age at 45, with 96% women.

In 2024, Dr. Lamar wrote 335 Medicare Part D claims for 86 patients. 85% of them were for generic drugs. CMS names the drug for 231 of them, across 8 drugs with 11 or more claims each, at $33,858 in total drug cost. In 2023, CMS named 167 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Lamar for performance year 2024, reported as part of a group. Dr. Lamar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lamar as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Lamar, published from 2020 to 2022. The most frequent topics are Early Detection of Cancer and Uterine Cervical Neoplasms. Dr. Lamar's most frequent co-authors are Melissa Greer Rosenstein, MD, George Franklin Sawaya, MD and Thoa Kim Ha.

Dmand AI lists 2 awards for Dr. Lamar, most recently CMS Stage 1 EHR in 2012.

Dr. Lamar graduated from UCSF School of Medicine in 2007.

Dr. Lamar is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.